{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T05:38:28Z","timestamp":1772948308266,"version":"3.50.1"},"reference-count":28,"publisher":"Cambridge University Press (CUP)","issue":"10","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S1047951121000688_as1\">\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Pulmonary arterial hypertension symptoms in systemic lupus erythematosus patients are non-specific and early diagnosis and intervention are challenging. It remains essential to explore risk factors for pulmonary arterial hypertension in systemic lupus erythematosus patients to identify high risk patients and allow intensive monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1047951121000688_as2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>From January 2010 to December 2018, 84 patients with systemic lupus erythematosus and pulmonary arterial hypertension and 160 patients with systemic lupus erythematosus but without pulmonary arterial hypertension were enrolled. Clinical manifestations and laboratory test results were compared between the two groups to identify predictors of pulmonary arterial hypertension. Candidate pulmonary arterial hypertension risk factors were further compared among systemic lupus erythematosus-pulmonary arterial hypertension patients with different characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1047951121000688_as3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among collected patient characteristics, Raynaud\u2019s phenomenon (OR 2.32, 95% CI: 1.17\u20134.61), digital vasculitis (OR 4.12, 95% CI: 1.48\u201311.49), pericardial effusion, pulmonary interstitial lesions, positive anti-u1 ribonucleoprotein antibodies, and positive anticardiolipin antibodies immunoglobulin G were associated with significantly higher risk of pulmonary arterial hypertension in systemic lupus erythematosus patients. Among these candidate risk factors, positive anti-u1 ribonucleoprotein antibody was independently associated with severe pulmonary arterial hypertension and more active disease. Digital vasculitis was independently associated with systemic lupus erythematosus alleviation, while pericardial effusion was associated with systemic lupus erythematosus deterioration. Pericardial effusion was associated with longer pulmonary arterial hypertension duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1047951121000688_as4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The significant association between studied clinical and laboratory indicators and risk of pulmonary arterial hypertension, pulmonary arterial hypertension and systemic lupus erythematosus characteristics suggested that these factors can be used to identify patients at higher risk of pulmonary arterial hypertension and adverse outcomes. Close monitoring may be indicated in patients with these risk factors, especially with more than one risk factor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s1047951121000688","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T05:52:57Z","timestamp":1615182777000},"page":"1619-1624","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":12,"title":["Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus"],"prefix":"10.1017","volume":"31","author":[{"given":"Yunxia","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7012-6491","authenticated-orcid":false,"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riqiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"S1047951121000688_ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311429815"},{"key":"S1047951121000688_ref14","first-page":"1","article-title":"Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies","volume":"9","author":"Tselios","year":"2017","journal-title":"Open Access Rheumatol"},{"key":"S1047951121000688_ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2011.104"},{"key":"S1047951121000688_ref26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00864.x"},{"key":"S1047951121000688_ref16","first-page":"1725","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Autoimmun Rev"},{"key":"S1047951121000688_ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314527366"},{"key":"S1047951121000688_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.034"},{"key":"S1047951121000688_ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2525-y"},{"key":"S1047951121000688_ref13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.1.182"},{"key":"S1047951121000688_ref27","doi-asserted-by":"publisher","DOI":"10.1002\/art.22265"},{"key":"S1047951121000688_ref28","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307087188"},{"key":"S1047951121000688_ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/854941"},{"key":"S1047951121000688_ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701093360207"},{"key":"S1047951121000688_ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.23303"},{"key":"S1047951121000688_ref19","first-page":"903","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Heart J"},{"key":"S1047951121000688_ref23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep203"},{"key":"S1047951121000688_ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.22069"},{"key":"S1047951121000688_ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040291"},{"key":"S1047951121000688_ref1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1327352"},{"key":"S1047951121000688_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.02.037"},{"key":"S1047951121000688_ref18","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"S1047951121000688_ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307080629"},{"key":"S1047951121000688_ref15","doi-asserted-by":"publisher","DOI":"10.5606\/ArchRheumatol.2019.6780"},{"key":"S1047951121000688_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(72)90064-2"},{"key":"S1047951121000688_ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002761"},{"key":"S1047951121000688_ref22","first-page":"267","article-title":"Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature","volume":"32","author":"Prete","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"S1047951121000688_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)02111-4"},{"key":"S1047951121000688_ref21","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0227"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951121000688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T09:17:31Z","timestamp":1647335851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951121000688\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1047951121000688"],"URL":"https:\/\/doi.org\/10.1017\/s1047951121000688","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-47892\/v1","asserted-by":"object"}]},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"\u00a9 The Author(s), 2021. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}